Smith Salley & Associates Raises Holdings in Abbott Laboratories (NYSE:ABT)

Smith Salley & Associates lifted its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 184,264 shares of the healthcare product maker’s stock after purchasing an additional 5,836 […]

Leave a Reply

Your email address will not be published.

Previous post Klingenstein Fields & Co. LP Cuts Stake in Abbott Laboratories (NYSE:ABT)
Next post 2,265 Shares in Broadcom Inc. (NASDAQ:AVGO) Bought by Valliance Asset Management Ltd